Inhibition of TACE activity enhances the susceptibility of myeloma cells to TRAIL.
TNF-related apoptosis-inducing ligand/Apo2 ligand (TRAIL/Apo2L) selectively induces apoptosis in various cancer cells including myeloma (MM) cells. However, the susceptibility of MM cells to TRAIL is largely low in most of MM cells by yet largely unknown mechanisms. Because TNF-α converting enzyme (...
Main Authors: | Kumiko Kagawa, Ayako Nakano, Hirokazu Miki, Asuka Oda, Hiroe Amou, Kyoko Takeuchi, Shingen Nakamura, Takeshi Harada, Shiro Fujii, Kenichiro Yata, Shuji Ozaki, Toshio Matsumoto, Masahiro Abe |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3289627?pdf=render |
Similar Items
-
Tgf-Beta inhibition restores terminal osteoblast differentiation to suppress myeloma growth.
by: Kyoko Takeuchi, et al.
Published: (2010-01-01) -
Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells.
by: Ayako Nakano, et al.
Published: (2011-01-01) -
Combination with a defucosylated anti-HM1.24 monoclonal antibody plus lenalidomide induces marked ADCC against myeloma cells and their progenitors.
by: Takeshi Harada, et al.
Published: (2013-01-01) -
Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
by: Pierleone Lucatelli, et al.
Published: (2021-02-01) -
Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
by: Pierleone Lucatelli, et al.
Published: (2021-07-01)